title: Do immunosuppressants directly affect neutrophils, resulting in protection of the liver against ischemia-reperfusion injury?
authors.forename: M
authors.initials: M
authors.lastname: Ohmori
authors.forename: E
authors.initials: E
authors.lastname: Kobayashi
authors.forename: K
authors.initials: K
authors.lastname: Harada
authors.forename: Y
authors.initials: Y
authors.lastname: Kitoh
authors.forename: K
authors.initials: K
authors.lastname: Mizuta
authors.forename: H
authors.initials: H
authors.lastname: Uchida
authors.forename: Y
authors.initials: Y
authors.lastname: Ogino
authors.forename: A
authors.initials: A
authors.lastname: Fujimura
mesh_terms: D000818:Animals; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007511:Ischemia / Q000517:prevention & control*; D008102:Liver Circulation / Q000187:drug effects*; D009504:Neutrophils / Q000187:drug effects*; D015427:Reperfusion Injury / Q000517:prevention & control*
chemical_list: D007166:Immunosuppressive Agents